SILVERARC CAPITAL MANAGEMENT, LLC Compass Therapeutics, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$598,000
portfolio value

Compass Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 262.09K shares 598K $2.28 262.09K